In 2010, researchers found that in colorectal cancer, FOXQ1 promoted tumorigenicity and tumor growth by upregulating p21 expression, which in turn enhanced angiogenesis and anti-apoptosis. Here, FOXQ1 is linked to colorectal cancer.